Medicure (MCUJF) Cash from Operations (2010 - 2026)
Medicure's (MCUJF) quarterly Cash from Operations came in at 1330800.39 in Q1 2026, down 391.09% year-on-year from 457177.21 in Q1 2025, and down 5899.51% quarter-over-quarter from 22946.76 in Q4 2025.
Medicure (MCUJF) Cash from Operations (2010 - 2026) Analysis & Trends
Medicure's Cash from Operations history runs 17 years deep, the most recent figure standing at 1330800.39 for Q1 2026.
- On a quarterly basis, Cash from Operations fell 391.09% year-over-year to 1330800.39 in Q1 2026; TTM through Mar 2026 was 2211105.61, a 245.12% decrease from a year earlier, with the FY2025 full-year figure at 400804.0, down 139.85% from the prior year.
- Cash from Operations eased to 1330800.39 in Q1 2026 per MCUJF's latest filing, from 22946.76 in the prior quarter.
- Across five years, Cash from Operations topped out at 1652895.67 in Q4 2024 and bottomed at 1330800.39 in Q1 2026.
- The 5-year median for Cash from Operations is 75457.12 (2025), against an average of 145508.76.
- Biggest YoY gain for Cash from Operations was 566.7% in 2025; the steepest drop was 2298.67% in 2025.
- Year by year, Cash from Operations stood at 1019005.76 in 2022, then tumbled by 33.18% to 680914.43 in 2023, then surged by 142.75% to 1652895.67 in 2024, then sank by 98.61% to 22946.76 in 2025, then slumped by 5899.51% to 1330800.39 in 2026.
- Per Business Quant, the three latest MCUJF Cash from Operations figures stand at 1330800.39 (Q1 2026), 22946.76 (Q4 2025), and 377123.57 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | -1.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.33 Mn |
| Mar 31, 2026 | -1.33 Mn |
| Dec 31, 2025 | 22,946.76 |
| Dec 31, 2025 | 22,946.76 |
| Sep 30, 2025 | -377,123.57 |
| Sep 30, 2025 | -377,123.57 |
| Jun 30, 2025 | -526,128.41 |
| Jun 30, 2025 | -526,128.41 |
| Mar 31, 2025 | 457,177.21 |
| Mar 31, 2025 | 457,177.21 |
| Dec 31, 2024 | 1.65 Mn |
| Dec 31, 2024 | 1.65 Mn |
| Sep 30, 2024 | -564,451.13 |
| Sep 30, 2024 | -564,451.13 |
| Jun 30, 2024 | -21,934.22 |
| Jun 30, 2024 | -21,934.22 |
| Mar 31, 2024 | -97,958.94 |
| Mar 31, 2024 | -97,958.94 |
| Dec 31, 2023 | 680,914.43 |
| Dec 31, 2023 | 680,914.43 |